Monitoring the compliance to lithium treatment;Monitoramento da adesão ao tratamento com lítio

Revista de Psiquiatria Clinica

Volumn 33, Issue 5, 2006, Pages 249-261

  Rosa, Adriane Ribeiro ^a   Kapczinski, Flávio ^b   Oliva, Renata ^c   Stein, Airton ^b,c   Barros, Helena Maria Tannhauser ^c,d  

^a Fundação Faculdade Federal de Ciências Médicas de Porto Alegre   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adherence; Lithium carbonate; Patient compliance; Red cell lithium; Serum levels

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMILORIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CARBOLIM; CARBOLITHIUM; CITALOPRAM; CLOZAPINE; DICLOFENAC; ETACRYNIC ACID; FLUOXETINE; FLUVOXAMINE; FUROSEMIDE; GABAPENTIN; HALOPERIDOL; IBUPROFEN; IMIPRAMINE; LAMOTRIGINE; LITHIUM; LITIOCAR; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PHENYLBUTAZONE; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE;

BIPOLAR DISORDER; DEPRESSION; DIARRHEA; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG MONITORING; DRUG POTENTIATION; ERYTHROCYTE; FATIGUE; HUMAN; MANIA; MUSCLE DISEASE; NAUSEA; OUTPATIENT CARE; PATIENT COMPLIANCE; POLYDIPSIA; POLYURIA; PRESCRIPTION; REVIEW; SCIENTIFIC LITERATURE; SELF REPORT; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; THYROID DISEASE; TREMOR; VOMITING;

EID: 33751270383     PISSN: 01016083     EISSN: 1806938X     Source Type: Journal    
DOI: 10.1590/s0101-60832006000500005     Document Type: Review

References (61)

1. ADAMS, J.; SCOTT, J. - Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 2: 119-124, 2000.
2. ANDERSON, P.O.; KNOBEN, J.E.; TROUTMAN, W.G. - Lithium. In: Anderson PO, Knoben JE, Troutman WG Handbook of Clinical Drug Data. 10.ed, Mc Graw-Hill, Nova York, pp. 480-481, 2002.
3. APSELOFF, G.; MULLET, D.; WILNER, K.D. et al. - The effects of ziprasidone on steady state lithium levels and renal clearance of lithium. Br J Clin Pharmacology 49 (suppl 1): 61-64, 2000.
4. BAUER, M.S.; MITCHNER, L. - What is a "mood stabilizer"? An evidence-based response. Am J Psychiatry 161: 3-18, 2004.
5. BOWDEN, C.L.; BRUGGER, A.M; SWANN, A.C. et al. - Efficacy of dilvalproex vs lithium and placebo in the treatment of mania. JAMA 12: 918-924, 1994.
6. BREUEL, H.P.; MÜLLER-OERLINGHAUSEN, B.; NICKELSEN, T. et al. - Pharmacokinetic Interaction between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers. International J Clin Pharmacology and Therapeutic 33: 415-419, 1995.
7. BULTMAN, D.C.; SVARSTAD, B.L. - Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Ass 1: 36-43, 2002.
8. BURGESS, S.; GEDDES, J.; HAWTON, K. et al. - Lithium for maintenance treatment of mood disorders (Cochrane Review). In: The Cochrane Library, 4: 1-35, Oxford: Update Software, 2002.
9. CALLAGHAN, J.T.; BERGSTROM, R.F.; PTAK, L.R. et al. - Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinetic 37: 177-193, 1999.
10. CAMUS, M.; HENNERÉ, G.; BARON, G. et al. - Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity. Eur J Clin Pharmacol 59: 583-587, 2003.
11. CANAL, M.; LEGANGNEUX, E.; VAN LIER, J.J. et al. - Lack of effect of amisulpride on the pharmacokinetics and safety of lithium. Int J Neuropsychopharmacol 6: 103-109, 2003.
12. CARSON, S.W. - LITHIUM. IN: EVANS, W.E.; SCHENTAG, J.J.; JUSKO, W.J. Principles of therapeutic drug monitoring. 3.ed. Applied Pharmacokinetics, Vancouver, 1992.
13. CHEN, C.; VERONESE, L.; YIN Y. - The effects of lamotrigine on the pharmacokinetics of lithium. Br J Clin Pharmacology 50: 193-195, 2000.
14. CLARCK, D.J.; PICKLES, J. - Lithium treatment for people with learning disability: patients' and carers' knowledge of hazards and attitudes to treatment. J Intellect Disabil Res 38: 187-194, 1994.
15. COLOM, F.; VIETA, E.; MARTINEZ-ÁRAN, A. et al. - A Randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 60: 402-407, 2003.
16. CRABTREE, B.L.; MACK, J.E.; JOHNSON, C.D. et al. - Comparison of the effects of hydrochlorothiazide and furosemide on lithium disposition. Am J Psychiatry 148: 8, 1991.
17. CRAMER, J.A.; MATTSON, H. - Compliance with antiepileptic drug therapy. In: Levy, R.H.; Meldrum, B.S. (ed.) Antiepileptic Drugs. 4.ed. Nova York, Raven Press, pp. 149-159, 1995.
18. DHARMENDRA, M.S.; EAGLES, J.M. - Factors associated with patients' knowledge of and attitudes towards treatment with lithium. J Affect Disord 75: 29-33, 2003.
19. DUBOVSKY, S.L.; FRANKS, R.D.; ALLEN, S. - Verapamil: a new antimanic drug with potential interactions with lithium. J Clin Psychiatry 48: 371-372, 1987.
20. FRAZER, A.; MENDELS, J.; BRUNSWUCK, D. et al. - Erythrocyte concentrations of the lithium ion: clinical correlates and mechanisms of action. Am J Psychiatry 9: 135-139, 1978.
21. GEORGE, C.F.; PEVELER, R.C.; HEILIGER, S. et al. - Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Pharmacol 50: 166-171, 2000.
22. GOODWIN, F.K. - Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry 63 (suppl. 10): 10-12, 2002.
23. HARVEY, N.S.; KAY, R. - Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse. J Clin Psychopharmacol 11: 362-367, 1991.
24. HARVEY, S.N. - The development and descriptive use of the lithium attitudes questionnaire. J Affect Disord 22: 211-219, 1991.
25. HAYNES, R.B.; MCDONALDS, H.P.; GARG, A.X. - Helping patients follow prescribed treatment. JAMA 288: 2880-2883, 2002.
26. HOPKINS, H.S.; GELENBERG, A.J. - Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disorder 2: 174-179, 2000.
27. KATHOL, R.G. - Effects of Theophylline on Lithium Clearance. J Clin Psychopharmacology 18: 237-240, 1998.
28. KECK, E.P.; MCELROY, S.L.; STRAKOWSKI, S.M. - Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 59 (suppl 6): 74-81, 1998.
29. KITCHING, J.B. - Patient Information Leaflets - the state of the art. J R Soc Med 83: 298-300, 1990.
30. KOOK, K.A.; STIMMEL, G.L.; WILKINS, J.N. et al. - Accuracy and safety of a prior lithium loading. J Clin Psychiatry 46: 45-51, 1985.
31. KOROLKOVAS, A. - Dicionário Terapêutico Guanabara. Ed. 2001/2002, Guanabara Koogan, Rio de Janeiro.
32. LINGAM, R.; SCOTT, J. - Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105: 164-172, 2002.
33. LINGJAERDE, O.; EDLUND, A.H.; GORMSEN, C.A. et al. - The effect of lithium carbonate in combination with tricyclic anti-depressants in endogenous depression. Acta Psychiatry Scand 50: 233-242, 1974.
34. LOBECK, F. - A review of lithium dosing methods. Pharmacotherapy 8: 248-255, 1988.
35. MALAMUD D, TABAK L. Saliva as a diagnostic fluid. Annals of the New York Academy of Sciences 694, 1993
36. citado em Fischbach F- A manual of laboratory and diagnostic tests 7th ed. Lippincott Williams & Wilkins 2004, pg 1244, Philadelphia.
37. MAJ, M.; PRIOZZI, R.; KEMALI, D. - Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology 8: 535-538, 1989.
38. MATTHEW, J.E. - Ellenhorn's Medical Toxicology. Diagnosis and Treatment of Human Poisoning. 2.ed., Williams & Wilkins, Baltimore, 1997.
39. MILJKOVIC, B.R.; POKRAJAC, M.; TIMOTIJEVIC, J. et al. - The Influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients in combined fluvoxamine-lithium therapy. Int Clin Psychopharmacology 12: 207-212, 1997.
40. POTKIN, S.G.; THYRUM, P.T.; BERA, R. et al. - Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. Clin Therapeutics 24: 1809-1823, 2002.
41. PRIEN, R.F.; KLETT, J.; CAFFEY, E.M. - Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 29: 420-425, 1973.
42. RAGHEB, M.; POWELL, A.L. - Lithium interaction with sulindac and naproxen. J Clin Psychopharmacology 6: 150-154, 1986.
43. ROSA, A.R.; MARCO, M.; FACHEL, J.M.G.; KAPCZINSKI, F.; STEIN, A; BARROS, H.M.T. - Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog in Neuro-psychopharmacol and Biol Psychiatry (artigo em fase de publicação, por isso a data ainda não é mencionada).
44. SACHS, G. - Unmet clinical needs in bipolar disorder. J Clin Psychopharmacol 3 suppl 1: S2-8., 2003.
45. SADEGHIPOUR-ROUDSARI, H.R.; FARAHANI, M.; SHOKRGOZAR, A.A. et al. - Decrease in erythrocyte: plasma lithium ratio by concurrent administration of psychotropic drugs and lithium in mice. Gen Pharmacology 31: 63-66, 1998.
46. SAFFER, D.; COPPEN, A. - Furosemide: a safe diuretic during lithium therapy? J Affect Disord 5: 289-292, 1983.
47. SASHI, S.; BRIAN, L.; COOK A. et al. - Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness. J Affect Disord 9: 219-222, 1985.
48. SCHOU, M. - Perspectives on lithium treatment of bipolar disorder: action, efficacy, effect on suicidal behavior. Bipolar Disorder 1: 5-10, 1999.
49. SCHOU, M. - Lithium Treatment at 52. J Affect Disord 67: 21-32, 2001.
50. SCHUMANN, C.; LENZ, G.; BERGHÖFER, A. et al. - Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res 89: 247-257, 1999.
51. SCOTT, J.; POPE, M. - Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 63: 384-390, 2002.
52. SHALMI, M.; THOMSEN, K. - Inhibition of tubular lithium reabsorption by amiloride in the conscious sodium-restricted rat. Eur J Pharmacology 230: 33-39, 1993.
53. SPINA, E.; PERUCA, E. - Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsy 43: 37-44, 2002.
54. SPROULE, B. - Lithium in bipolar disorder: Can drug concentrations predict therapeutic effect? Clin Pharmacokinet 41: 639-660, 2002.
55. SUMMERTON, A.M.; HARVEY, N.S.; FORREST, A.R.W. - New direct method for measuring red cell lithium. J Clin Pathology 42: 435-437, 1989.
56. SVARSTAD, B.; SHIEREMAN, B.; SWEENEY, J.K. - Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Sev 52: 805-811, 2001.
57. TEITELBAUM, M. - A significant increase in lithium levels after concomitant ACE inhibitor administration. Psychosomatics 34: 450-453, 1993.
58. THOMPSON, K.; KULKARNI, J.; SERGEJEW, A.A. - Reability and validity of a new medication adherence rating scale (EAM) for the psychoses. Schizophrenia Res 42: 241-247, 2000.
59. TÜRCK, D.; HEINZEL, G.; LUIK, G. - Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam. Br J Clin Pharmacology 50: 197-204, 2000.
60. VARGAS, C.; TANNHAUSER, M.; TANNHAUSER, S.L. et al. - Lithium and valproate combined administration: acute behavioural effects and drug plasma level. Pharmacol Toxicol 79: 87-91, 1996.
61. VISMARI, L.; PIRES, M.L.N.; BENEDITO-SILVA, A.A.; CALIL, H.M. - Bioavailability of immediate and controlled release formulations of lithium carbonate. Rev Bras Psiquiatr 24: 74-92, 2002.